Business Wire
SanMelix Laboratories Wins Stevie® Award in 2021 American Business Awards® for its BEECure™ Line
SanMelix Laboratories
Helping You Heal with Honey
HOLLYWOOD, FL
Health Tech
Helping people live happier, healthier lives through superior natural remedies and distinct treatment components to provide faster and more effective wound and skin care.
$136,960
raised
$1,069,997
previously crowdfunded
124
Investors
$23.8M
Valuation
$1.50
Price per Share
$238.50
Min. Investment
Common
Shares Offered
Equity
Offering Type
$3.93M
Offering Max
0
Days Left
This offering ended on January 12, 2022 and is no longer accepting investments.
Reasons to Invest
First buckwheat honey-based wound dressing patented formulations with anticipated FDA microbial claim for infection control
Our advanced wound care dressings will address the antimicrobial resistance (AR) crisis along with hospital acquired infection (HAI) prevention
Only dressing that has all three mechanisms of wound healing *Anti-microbial claim *Autolytic debridement * Skin regeneration
Our mission is faster healthier healing
OVERVIEW
Invest in SanMelix
SanMelix is a bioactive skin and wound care company using the natural healing properties of Buckwheat honey, combined with our advanced bioactive enhancements. SanMelix has created products that aid in the healing of acute, chronic, and minor wounds. Our goal is to enhance our market position in the global Skin and Wound Care market.
BEECure™ M is not currently available on the market. This product is pending 510(k) submission.
In light of the current Covid-19 Pandemic, there has been a rise in healthcare admissions and an increased awareness of infection control. With IP protection on our BEECure™ M dressing and other pending patents, co-created by a renowned Harvard trained podiatric physician, SanMelix's advanced bioactive skin and wound care products can be used in a host of settings and situations. With the CDC investing $300M+ in 59 state & local health departments to detect and prevent resistant threats, our advanced wound care dressings are ideal for HealthCare Associated Infections (HAIs) and the Antimicrobial Resistance (AR) crisis by reducing microbial growth to prevent life threatening bacteria (e.g. MRSA) from penetrating the dressing while in use.
Our goal is to improve the lives of patients and help speed up the healing process using the natural therapeutic properties that already exist in buckwheat honey. Honey has been used in medicine since 8000 BC because of its unique healing properties and with our team of doctors and scientists, we have enhanced it through the use of broad-spectrum antimicrobials. Dr. Sabacinski has been working in the wound care space for over thirty years, and he knows the patients’ needs for a product that encourages fast wound closure and provides protection from bacteria and infection. Our mission at SanMelix is to help people live happier, healthier lives by providing fast and effective wound and skin care through superior natural remedies. We want to give caregivers, physicians, and the general public the ability to heal wounds using a natural product that has been used for centuries. At SanMelix, the proof is in our buckwheat honey.
THE MARKET
The entire population requires wound care
- Global Skin and Wound Care Market Is Expected to Reach USD 25.98 Billion by 2025
- 50 million people annually are affected by hard to close wounds worldwide
- A failure to address the problem of the Antimicrobial Resistance (AR) could result in 10 million people dying per year by 2050.
- Chronic wounds affect over 5.7 million patients in the U.S. alone and are estimated to cost $20 billion annually, thus impacting the market growth positively
- Each year, about 1 in 25 U.S. hospital patients is diagnosed with at least one infection related to hospital care alone; additional infections occur in other healthcare settings
- Everyday people require wound care therapies for minor burns, cuts, scrapes, abrasions, and rashes
- Of the 3 million patients in the United States receiving radiation 85% experience moderate to severe skin reactions.
THE PROBLEM
Human wounds and its burden
- Many Healthcare Associated Infections HAIs are caused by the most urgent and serious antibiotic-resistant (AR) bacteria and may lead to sepsis or death.
- Up to one-third of the half billion people with diabetes worldwide will develop a diabetic foot ulcer (DFU). Of these, 17% will require an amputation.
- There are few effective therapies for radiotherapy, laser therapy and minor thermal burns
the solution
Using buckwheat honey products, we can solve them
- Our BEECure™ M (buckwheat honey MGO) patented formulation prevents HAI’s by reducing microbial growth to prevent life threatening bacteria (MRSA) from penetrating the dressing while in use
- Case studies using BEECure™ M illustrated accelerated healing and skin regeneration on severe limb threatening wounds
- Our BEECure™ R was developed with buckwheat honey and calming calendula that soothes, hydrates, and revives skin affected by radiation and laser therapy, as well as those exposed to heat and sun.
WHAT WE DO
We create products using Buckwheat Honey
We are focusing on the unique medicinal properties of Buckwheat Honey for tissue regeneration and accelerated healing. Our bioactive buckwheat honey formulations demonstrate intrinsic healing activity with anti-microbial additives to prevent infection. SanMelix has created and will continue to create products utilizing Buckwheat honey. SanMelix currently has two patents on its BEECure™ M formulation and Dr. Sabacinski has co-invented 1 additional patent pending natural Buckwheat Honey BEECure™ medical device which also demonstrated superior clinical outcomes. Studies have proven that buckwheat honey has superior medicinal properties to Manuka honey and other natural remedies. Our products also have higher standardization and broader spectrum anti-microbial activity achieving consistent clinical outcomes. Buckwheat honey also has higher anti-inflammatory and anti-oxidant activities than other products currently being used.
Our patented advanced wound care (AWC) dressing will be the only product in the market that meets all the requirements of an ideal wound dressing, debridement, tissue repair, and anti-microbial properties. The anti-oxidant properties in Buckwheat honey assist in wound closure and help to stimulate the wound healing process. This means wounds are healing faster and better without the risk of further complications that could be a great hindrance to the lives of patients. Our Buckwheat honey patented formulation prevents life-threatening bacteria from penetrating through the dressing while it is in use. The nutrients in the honey help spur tissue regeneration because it contains large quantities of easily assailable sugars, amino acids, vitamins, specifically vitamin C. Our (AWC) products are made to heal chronic and difficult to close wounds.
This product is pending FDA approval.
Products in Use
Our BEECure™ skin and wound care products are categorized into two business segments with each being formulated with the common ingredient of buckwheat honey. Our BEECure™ R -Radiation and Laser skin Care cream launched on Amazon in February 2021 and received the Amazon Choice award in the first month. Our advanced wound care products will also be used in hospitals and rehabilitation centers, by physicians through the use of dressings and ointments.
BEECure® M is not currently available on the market. This product is pending 510(k) submission.
Because of the anticipated anti-microbial claim in our AWC dressings, they will be instrumental in the treatment and healing of:
- Ulcers, diabetic and otherwise
- Skin grafts
- Partial Thickness Burns
- Trauma and triage
- Surgical Site Infections
In addition to our AWC products, SanMelix buckwheat honey-based OTC Skin Care cream and ointments can be used for the treatment of:
- Radiation and Laser Skin Care
- Sunburns
- Minor burns
- Diabetic foot ulcer cream
- Acne
- Eczema
HOW WE ARE DIFFERENT
The difference is in the ingredients
Although manuka honey is the most commonly used honey-based wound treatment on the market, studies have shown that buckwheat honey has superior inherent healing properties when compared to manuka honey due to its higher anti-inflammatory and higher anti-oxidant activities. In addition, SanMelix’ s advanced wound care products have been fortified with antimicrobials to ensure a higher standardized and broader spectrum antibacterial activity. Our patented formulation utilized in our AWC dressings permits SanMelix to launch one of the first bioactive honey dressing to make an antimicrobial claim in the U.S. Our honey dressing is currently undergoing the FDA regulatory 510(k) clearance process. Our bioactive dressing will be for any wound type of any depth and severity. The dressing will prevent biofilms from forming, control wound odor, reduce pain and treatment time while being cost-effective and more environmentally sound.
Additionally, there will be improved skin and tissue regeneration and debriding action. This prevents the necessity for excess skin grafts or skin substitutes, which run the added risk of infection or rejection. Studies have shown buckwheat honey has bactericidal activity against antibiotic-resistant pathogens. In addition, our 510(k) testing for BEECure™ M demonstrated the efficacy of our dressing against these super infections.
The bottom line is that our enhanced Buckwheat honey dressings and ointments are making the lives of patients and doctors easier. We are here to assist in the healing process and make a painful experience as painless as possible. We have seen firsthand the need for such products as the ones we have been creating and know that our BEECure® products are going to be a big step forward in changing the lives of many.
Our patented advanced wound care dressing will be the only product in the market that meets all the requirements of an ideal wound dressing, debridement, tissue repair, and anti-microbial properties.
Characteristics of an ideal wound dressing
Harnessing the power of nature and science with Buckwheat honey and calendula, SanMelix launched BEECure R radiation and laser skin care. These natural nutrients nourish and hydrate the skin, help restore elasticity and revive dry skin.
OUR TRACTION
Our products have been proven to be safe & effective in early studies
- We reached our crowdfunding goal of $1.07M, and have 1,725 investors on StartEngine
- We launched our BEECure ™ R-radiation and laser skin care on Amazon and Walmart.com
- We have completed testing on our advanced wound care products and will apply for 510(k) pre-market clearance from the FDA in Q3 2021
- We secured a secondary US honey supplier and purchased US manufacturer worldwide formulation rights for BEECure™ R -Radiation and Laser Skin Care which reduces our overall manufacturing cost
- We were granted 2 US patents and 1 Canadian patent and will continue prosecuting our other patent pending formulation application. US trademarks were issued in Q2 2021. Company has also filed an international trademark
Traction by year:
On top of this, we are negotiating with other cGMPs to contract manufacture our skin and wound care products. With the funds raised through StartEngine, we plan to complete an evidence-based clinical trial for widespread clinical adoption on our advanced wound care dressing and move to commercialization. Develop, test, and commercialize additional Skin and Wound Care OTC products as well as build up inventory. In addition, we will hire manufacturing, operations, and sales and marketing executives, while continuing to prosecute patents and trademarks.
We are thrilled about the future opportunities that are in store for the SanMelix team and the effect our nature-based products will have on healing.
WHY INVEST
There are over 50 million reported cases globally of patients suffering from hard-to-close wounds. 15% of these are diabetic foot ulcers that eventually lead to amputation. With natural Buckwheat Honey, proven to have superior healing and skin care outcomes, at its core, BEECure™ is the only dressing to contain the three essential components of skin and wound care. Antioxidants to boost continuous healing, superior anti-bacterial properties for wound cleansing and heightened resistance against infections, and natural anti-inflammatory and humectant properties to soothe, regenerate and revitalize skin.
SanMelix BEECure™ bioactive skin and wound care products are here to treat everything from a minor scrape to a severe wound and everything in between. Using our unique enhanced Buckwheat honey patented formulations fortified with microbial barriers, we are treating all types of dermal afflictions by speeding up the healing process and reducing pain and the risk of infection. We will be first to market buckwheat honey skin and wound care products in the United States. Our patented advanced wound care dressing will assist with the complexities of combating Hospital Associated Infections (HAIs) across healthcare settings and in the community.
Honey is a product that has been used all throughout history as a healing and restorative agent, and we are harnessing its natural powers and using our years of scientific and medicinal studies to enhance it. We are regulating it to make it safe for hospital use, as well as selling it OTC to the average consumer. Everyone should be able to experience the benefits of the BEECure™ Buckwheat honey products.
Our customers will include the VA & DoD, medical supply distributors, physician networks, hospitals, SNFs as well as indirect sales channel for private label/ white label for OTC opportunities. We will market directly to OTC consumers through the world wide web, pharmacies, retails stores, and indirect sales channel for private label/white label. We are capitalizing on a market that has been desperately in need of a natural and safe product that promotes healing and tissue growth while providing infection control. With our current traction and growth, we will continue to innovate new products and work on opening up key distribution regions across the country. To increase brand awareness, we have hired a successful sales advisor. We now have greater ability to create and design sales materials to engage in digital marketing
We have a talented and world-renowned physician group who puts patient care first. Our goal is to improve patients' lives in need of healing with our innovative bioactive skin and wound care products.
(Source, Source, Source, Source)
Quick Insert
Drop image
(or click)
(or click)
Advanced Edit
Drop image
(or click)
(or click)
In the Press
The American Business Awards
Product Management & New Product Awards
Health Journal
SanMelix Lab Courts StartEngine Investors with Honey Wound-Care Products
Stock News Now
SanMelix Laboratories, Inc. - Bioactive Wound Care Company Discusses BEECure™, Approval Process, IP Protection and Growth Drivers
CEO CFO
Faster and Healthier Healing
Offering Summary
Company | : | SanMelix Laboratories, Inc. |
Corporate Address | : | 1150 North 35th Avenue Suite 225, HOLLYWOOD, FL 33021 |
Offering Minimum | : | $9,999.00 |
Offering Maximum | : | $3,930,001.50 |
Minimum Investment Amount(per investor) | : | $238.50 |
Terms
Offering Type | : | Equity |
Security Name | : | Class NV Common Stock |
Minimum Number of Shares Offered | : | 6,666 |
Maximum Number of Shares Offered | : | 2,620,001 |
Price per Share | : | $1.50 |
Pre-Money Valuation | : | $23,791,443.00 |
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
If you invest $500+, you will receive 3% bonus shares.
If you invest $1,000+, you will receive 5% bonus shares.
If you invest $2,000+, you will receive 10% bonus shares.
If you invest $5,000+, you will receive 15% bonus shares.
If you invest $10,000+, you will receive 20% bonus shares.
All Invested shareholders receive 20% off our Radiation & Laser Skin Care on Amazon. Check Your Email for Discount Code.
*All perks occur when the offering is completed.
The 10% Bonus for StartEngine Shareholders
SanMelix Laboratories Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $1.50 / share, you will receive and own 110 shares for $150. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.
Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$460,947.00
USD
$237,064.00
USD
Cash And Cash Equivalents
$264,467.00
USD
$51,318.00
USD
Accounts Receivable
$0.00
USD
$0.00
USD
Short Term Debt
$0.00
USD
$0.00
USD
Long Term Debt
$43,334.00
USD
$0.00
USD
Revenues And Sales
$0.00
USD
$0.00
USD
Costs Of Goods Sold
$0.00
USD
$0.00
USD
Taxes Paid
$0.00
USD
$0.00
USD
Net Income
-$404,179.00
USD
-$226,917.00
USD
Risks
A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.
Updates
Final Hours to Invest in SanMelix!
16 days ago
SanMelix Community, 🍯
This is your LAST chance to invest in SanMelix on StartEngine!
If you’ve been waiting until the last minute to hop on board our investor community, now is the time.
As we approach the final hours of our campaign, we wanted to take a moment to thank everyone who has shown us support throughout our campaign.
Thanks to you, we’re able to create an impact on the future of wound and skin care while helping people live healthier, more enjoyable lives.
It’s not too late!
Our campaign isn’t over yet, and we need your support now more than ever.
We strongly encourage anyone who has been considering investing in SanMelix, to please do so now.
Simply head over to our StartEngine raise page, and join us as a shareholder for as little as $238.50 before it’s too late.
Don’t let this opportunity pass you by!
We are looking forward to welcoming you to the SanMelix team.
Warmly,
Diana Sabacinski
CEO
SanMelix
Only 3 Days Left to Invest on StartEngine!
20 days ago
SanMelix Community,
The clock is ticking…
As our equity crowdfunding campaign comes to an end, we would like to take a moment to remind you all that there are only 3 days left to invest!
We produce natural products to help people live happier, healthier lives through our effective approach to wound and skin care.
We are looking for like-minded individuals who share our vision in creating a better future for all!
Get your foot in the door of a $26B industry before it's too late.
Don’t miss this opportunity! Head over to our raise page and join us as an early investor today!
Thank you for your support. The SanMelix team is looking forward to a strong finish with you as a part of our community.
Bee well.
Warmly,
Diana Sabacinski
CEO
SanMelix
Your Chance to Re-Invest is Running Out!
21 days ago
SanMelix Community,
This is a friendly reminder that there are only 5 days left to invest in SanMelix on StartEngine!
We are a global skin and wound care company with a natural, non-invasive approach to treating wounds.
Our mission is to improve the lives of patients and help speed up the healing process, using the natural therapeutic properties that already exist in buckwheat honey.
If you’ve been considering investing in us, now is the time!
Head over to our StartEngine raise page and join us as an early shareholder, before it’s too late!
Don’t miss out on this unique opportunity!
The SanMelix team is looking forward to a strong finish with you as a part of our community.
Warmly,
Diana Sabacinski
CEO
SanMelix
Less Than 2 Weeks Left to Invest in SanMelix!
29 days ago
SanMelix Community,
There are officially only two more weeks left to invest in our equity crowdfunding campaign on StartEngine!
Our mission is to improve lives by delivering faster, healthier wound healing and happier, younger looking skin.
We believe in the importance of people taking care of their health and wellness, which is why we created SanMelix - a brand of natural remedies that help people heal faster and feel better every day.
Interested in helping us create an impact?
Head over to our raise page and join us as an early investor, while time permits!
We look forward to a strong finish in our campaign with you as a part of our rapidly growing community.
Thank you for your support in bringing the SanMelix vision to fruition.
Warmly,
Diana Sabacinski
CEO
SanMelix
Notice of Funds Disbursement
about 1 month ago[The following is an automated notice from the StartEngine team].
Hello!
As you might know, SanMelix Laboratories has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in SanMelix Laboratories be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
Sneak Preview
about 1 month agoHi Everyone,
We are delighted to announce we will be launching new products on Amazon in January 2022.
We’ve combined nature and science to bring you revolutionary, award winning products that we believe will be a household name in the future! Our equity crowdfunding campaign is ending in 20 days, so act fast and tell your friends and family to become part of our family today! Make a difference by improving the lives of others.
Thank you for your continued support, and belief in our vision.
BEE Well,
Diana
Follow SanMelix on Social Media! 😊
about 1 month ago
SanMelix Community, 🍯
We are the next generation of wound and skin care products.
SanMelix aims to create happier healthier lives with our superior natural remedies, combining nature and science to ensure satisfaction with your treatment.
Our innovative company is growing rapidly, and things are happening fast!
We want to make sure you're always up-to-date with the latest and greatest from SanMelix, so make sure to follow us on all of our social media platforms.
This will only take a second.
Facebook - https://www.facebook.com/Sanmelix01/
Linkedin - https://www.linkedin.com/company/sanmelix-laboratories-inc/
Instagram - https://www.instagram.com/sanmelixlaboratories/
Twitter - https://twitter.com/sanmelixlabs?lang=en
Thank you for supporting, and our team is looking forward to keeping you posted on exciting products and achievements in the near future!
Our equity crowdfunding raise is far from over, head over to our StartEngine raise page and join our investor community!
BEE Well,
SanMelix Team
Lead Investor Raves About SanMelix!
about 1 month agoSanMelix Community,
As you may know, Sanmelix is a proven leader in wound and skin care.
With our patented formulations combining nature and science, we offer a breadth of high-quality natural remedies and treatments that are all backed by clinical research.
One of our lead investors, Evan Greenberg, portfolio manager of the LegendCap Opportunity Fund, recently gave us with a compelling testimonial video!
At LegendCap, Evan and his team understand that when it comes to investments, it’s not all just about profit. It’s about investing in products that are going to make the world a better place.
He is elated with his partnership in SanMelix, knowing that our proven Buckwheat Honey solutions are a much better alternative to most products that are artificially created in a lab.
By getting our products patented, it allows us a better opportunity of getting a Premarket Notification 510(K) so that all of our products are able to be sold commercially.
Some of our products are already being sold over the counter and through Amazon, so it’s quite possible that SanMelix will become a household name in the years to come.
Evan believes that the ability to affect change through life sciences without having to spend top dollar is very valuable.
This is something that the average investor can appreciate and resonate with.
He is equipped with the knowledge that SanMelix stands a very sustainable competitive advantage, and it’s not just about the development of the products.
It’s also about our management team that’s behind it, the addressable market that we’re serving, and what are some of the big trends in health care these days.
For more information, we encourage you to watch the full investor testimonial video from our dear friend Even Greenberg!
Our equity crowdfunding raise is far from over, and we’re looking for like-minded individuals who believe in making an impact to better our world’s future.
If this sounds like you, head over to our raise page and join our investor community today!
We look forward to having you as part of the SanMelix family.
BEE Well,
SanMelix Team
Please be aware that this testimonial may not be representative of the experiences of other customers and are not a guarantee of future performance and success.
Less than 30 days left to invest!
about 1 month ago
SanMelix Community,
SanMelix is a revolutionary wound and skin care company that offers advanced, innovative, and safe treatment options for patients around the world.
We’ve combined nature and science to bring you revolutionary, award winning products that we believe will be a household name in the future!
We are currently seeking investors to support us in our mission for faster, healthier healing.
Our equity crowdfunding campaign is ending in less than a month, so act fast!
If you believe in making a difference by improving the lives of others, visit our raise page and join our community of early shareholders today.
If you have any questions or comments, please do not hesitate to reach out to our team on the comment section of our StartEngine page and we will be more than happy to address them for you.
Thank you for your continued support, and belief in our vision.
Warmly,
Diana Sabacinski
CEO
SanMelix
SanMelix’s Early Investor Perks! 💰
about 2 months ago
SanMelix Community, 🍯
At SanMelix, our mission is to bring the healing power of nature to as many people as possible.
We believe that everyone has the right to live happy, healthy lives, so we work to develop natural remedies that provide superior healing alternatives for our customers.
We've designed a number of perks with our “investomers”, or customers who believe in us enough that they want to jump aboard and invest. Here’s a list of the different tiers and what you will receive based on your investment:
$238+ - StartEngine Owner’s 10% Bonus program
Tier 1 ($500+) - 3% bonus shares
Tier 2 ($1000+) - 5% bonus shares
Tier 3 ($2,000+) - 10% bonus shares
Tier 4 ($5,000+) - 15% bonus shares
Tier 5 ($10,000+) - 20% bonus shares
What are you waiting for?
Head over to our raise page and join our community of early shareholders today!
We look forward to a strong campaign and keeping you updated on future milestones.
Diana Sabacinski
CEO
SanMelix
BEE Well
Sincerely, 
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}